AACR Annual Meeting 2021 – Poster 1480
Comparative cancer cell panel profiling of kinase inhibitors

Comparative cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020
Download poster (Pdf)

Discovery of Precision Oncology Drugs

NTRC provides in vitro drug discovery services focused on Precision Medicine. We help you to find the informed route to the clinic. Information can be found at www.oncolines.com

Comparative cancer cell panel profiling of kinase inhibitors

The poster presents the biochemical and cellular profiling of newly-approved kinase inhibitors and other inhibitors which act on the same target. The compounds are compared side by side based on their selectivity and potency on primary and secondary targets.

NTRC ONCOLINES™

Access Cancer Cell Lines, Proliferation Assays and Bioinformatics Analysis to Find Patient Stratification Markers

ONCOLINES

read more
NTRC SYNERGYFINDER™

Apply Combination Studies
to Identify
Novel Synergies

SYNERGYFINDER

read more
NTRC Mechanistic Cell Biology

Use Cell-Based Assays
to Determine
Mechanism of Action

MECHANISTIC CELL BIOLOGY

read more

Information Needed?

Please contact us for more information

+31 412 700500
Send e-mail